AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32305787 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose spinal analgesia
Number of subjects: 99
Study 32305787 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 99
Study 36181080 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete laparoscopic surgery with modified triangular anastomosis technique
Number of subjects: 86
Study 36181080 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic-assisted small incision colon reconstruction surgery
Number of subjects: 86
Study 34481517 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg (with loading dose)
Number of subjects: 555
Study 34481517 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg (without loading dose)
Number of subjects: 555
Study 34481517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 555
Study 32446674 — intervention group
Group type: EXPERIMENTAL
Intervention: Established Status Epilepticus Treatment Trial
Number of subjects: 317
Study 35206521 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered stop-smoking programme (group support, combination nicotine replacement therapy (NRT), and tailored individual support)
Number of subjects: 176
Study 34151822 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 52
Study 34151822 — intervention group
Group type: COMPARATOR
Intervention: Insole application
Number of subjects: 52
Study 32667053 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (non-breastfeeding mothers)
Number of subjects: 449
Study 32667053 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-breastfeeding mothers)
Number of subjects: 449
Study 35393757 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 2000
Study 35393757 — intervention group
Group type: EXPERIMENTAL
Intervention: High sensitive faecal immunochemical test (FIT)
Number of subjects: 2000
Study 35393757 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsubscribing from screening
Number of subjects: 2000
Study 35393757 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistical concerns about the screening procedure
Number of subjects: 2000
Study 35393757 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmation of participation
Number of subjects: 2000
Study 35393757 — intervention group
Group type: EXPERIMENTAL
Intervention: FIT screening difficulties or in need of a new FIT test
Number of subjects: 2000
Study 32071149 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin at 500, 1000 or 2000 mg/day for 1 week
Number of subjects: 0
Study 32071149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34580826 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised, facility-based aerobic exercise intervention (n=73)
Number of subjects: 213
Study 34580826 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention (n=69)
Number of subjects: 213
Study 34580826 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control group (n=71)
Number of subjects: 213
Study 34580826 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised, facility-based aerobic exercise intervention (n=73) among women with a family history of breast cancer
Number of subjects: 213
Study 34580826 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention (n=69) among women with a family history of breast cancer
Number of subjects: 213
Study 34162791 — intervention group
Group type: COMPARATOR
Intervention: Control group (not randomized to any intervention)
Number of subjects: 43
Study 35345792 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic trans-abdominal pre-peritoneal repair (TAPP)
Number of subjects: 100
Study 35345792 — intervention group
Group type: COMPARATOR
Intervention: Open Lichtenstein repair
Number of subjects: 100
Study 32233245 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of PRP (2 ml) and extra-articular injection of PRP (2 ml), once a week for three times.
Number of subjects: 48
Study 32233245 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injection of sodium hyaluronate (20 mg) and extra-articular injection of analgesic drug (2 ml for one point), once a week for three times.
Number of subjects: 48
Study 33387398 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel containing onion extract and aloe vera (SGOA)
Number of subjects: 40
Study 33387398 — intervention group
Group type: COMPARATOR
Intervention: Silicone gel sheets (SGS)
Number of subjects: 40
Study 33387398 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 32531968 — intervention group
Group type: EXPERIMENTAL
Intervention: Group with slow‐paced music at a tempo of 60 BPM (GS)
Number of subjects: 56
Study 32531968 — intervention group
Group type: EXPERIMENTAL
Intervention: Group with fast‐paced music at a tempo of 105 BPM (GF)
Number of subjects: 56
Study 32531968 — intervention group
Group type: COMPARATOR
Intervention: Group control without music (GC)
Number of subjects: 56
Study 35697424 — intervention group
Group type: EXPERIMENTAL
Intervention: TranS‐C plus usual care (TranS‐C+UC)
Number of subjects: 53
Study 35697424 — intervention group
Group type: COMPARATOR
Intervention: Usual care followed by delayed treatment with TranS‐C (UC‐DT)
Number of subjects: 53
Study 35697424 — intervention group
Group type: EXPERIMENTAL
Intervention: TranS‐C skills
Number of subjects: 53
Study 33847862 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months DAPT
Number of subjects: 1500
Study 33847862 — intervention group
Group type: COMPARATOR
Intervention: 12 months DAPT
Number of subjects: 1500
Study 35924333 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging Device (JD)
Number of subjects: 24
Study 35924333 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 24
Study 33857980 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE) in the midesophageal 4-chamber (ME 4Ch) view
Number of subjects: 25
Study 33857980 — intervention group
Group type: COMPARATOR
Intervention: Transthoracic echocardiography (TTE) in the apical 4-chamber (AP 4Ch) view
Number of subjects: 25
Study 33857980 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE) in the deep transgastric view (DTG)
Number of subjects: 25
Study 33857980 — intervention group
Group type: EXPERIMENTAL
Intervention: Speckle tracking-based strain rate in the ME 4Ch view
Number of subjects: 25
Study 33857980 — intervention group
Group type: COMPARATOR
Intervention: Speckle tracking-based strain rate in the AP 4Ch view
Number of subjects: 25
Study 33219673 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive weight-loss lifestyle intervention
Number of subjects: 228
Study 33219673 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 228
Study 32855972 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA (tranexamic acid)
Number of subjects: 40
Study 32855972 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 40
Study 33566146 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR with LET
Number of subjects: 20
Study 33566146 — intervention group
Group type: COMPARATOR
Intervention: ACLR
Number of subjects: 20
Study 33837098 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised respiratory care home-based (ORC) group
Number of subjects: 0
Study 33837098 — intervention group
Group type: COMPARATOR
Intervention: Conventional respiratory care (CRC) group
Number of subjects: 0
Study 36150864 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based psychological intervention (3 modules: support, education, and reflection)
Number of subjects: 114
Study 36150864 — intervention group
Group type: COMPARATOR
Intervention: Conventional face-to-face intervention and advice from clinical educators
Number of subjects: 114
Study 33877323 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid micellar preparation (1000 mg)
Number of subjects: 30
Study 33877323 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried colloidal suspension (300 mg)
Number of subjects: 30
Study 33877323 — intervention group
Group type: COMPARATOR
Intervention: Standard turmeric extract (1500 mg)
Number of subjects: 30
Study 33877323 — intervention group
Group type: COMPARATOR
Intervention: Piperine-curcuminoid combination (1515 mg)
Number of subjects: 30
Study 33877323 — intervention group
Group type: COMPARATOR
Intervention: Phytosome formulation (1000 mg)
Number of subjects: 30
Study 34782419 — intervention group
Group type: EXPERIMENTAL
Intervention: IV thrombolysis with alteplase at 0.9 mg/kg body weight
Number of subjects: 459
Study 34782419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study 34782419 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of CMBs
Number of subjects: 459
Study 34571144 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Group: patients hearing instrumental music through a headset during the entire procedure
Number of subjects: 107
Study 34571144 — intervention group
Group type: COMPARATOR
Intervention: No Music Group: patients wearing headphones without music
Number of subjects: 107
Study 34106300 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (SGLT2 inhibitor)
Number of subjects: 0
Study 34106300 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin (SGLT2 inhibitor)
Number of subjects: 0
Study 34106300 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenon (mineralocorticoid receptor antagonist)
Number of subjects: 0
Study 34106300 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 0
Study 34106300 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip® implantation
Number of subjects: 0
Study 34106300 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney replacement therapy initiation timing
Number of subjects: 0
Study 33727902 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic activities of daily living
Number of subjects: 90
Study 33727902 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 90
Study 33727902 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory
Number of subjects: 90
Study 33727902 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 90
Study 33727902 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial Making Test (B-A)
Number of subjects: 90
Study 33727902 — intervention group
Group type: EXPERIMENTAL
Intervention: Motoricity index
Number of subjects: 90
Study 36343424 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy (80 mJ) and high density (12.6%) - Group A (HeHd)
Number of subjects: 48
Study 36343424 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy (80 mJ) and low density (8%) - Group B (HeLd)
Number of subjects: 48
Study 36343424 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy (60 mJ) and low density (8%) - Group C (LeLd)
Number of subjects: 48
Study 35533724 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 3799
Study 34320508 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary tumor resection (PTR) in right-sided mCC
Number of subjects: 0
Study 34320508 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary tumor resection (PTR) in left-sided mCC
Number of subjects: 0
Study 32106274 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 polyunsaturated fatty acids
Number of subjects: 0
Study 32106274 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35221199 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 15
Study 35221199 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 15
Study 35221199 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous breathing (SB)
Number of subjects: 15
Study 32102617 — intervention group
Group type: EXPERIMENTAL
Intervention: Top quintile fish intake
Number of subjects: 26034
Study 32102617 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish intake
Number of subjects: 26034
Study 32102617 — intervention group
Group type: EXPERIMENTAL
Intervention: α-linolenic acid intake
Number of subjects: 26034
Study 32102617 — intervention group
Group type: EXPERIMENTAL
Intervention: Total n-3, docosahexaenoic acid, and α-linolenic acid intake
Number of subjects: 26034
Study 32102617 — intervention group
Group type: EXPERIMENTAL
Intervention: High eicosapentaenoic acid intake
Number of subjects: 26034
Study 35140309 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal mother's milk administration for 14 days
Number of subjects: 130
Study 35140309 — intervention group
Group type: COMPARATOR
Intervention: Oropharyngeal 0.9% normal saline administration
Number of subjects: 130
Study 32488680 — intervention group
Group type: EXPERIMENTAL
Intervention: CePROP = 3.6 μg⋅ml−1 and CeREMI = 4 ng⋅ml−1
Number of subjects: 80
Study 32488680 — intervention group
Group type: EXPERIMENTAL
Intervention: CePROP
Number of subjects: 80
Study 32488680 — intervention group
Group type: EXPERIMENTAL
Intervention: CeREMI
Number of subjects: 80
Study 32488680 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodynamic and arousal responses evoked by laryngoscopy
Number of subjects: 80
Study 32276630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet (KD)
Number of subjects: 21
Study 32276630 — intervention group
Group type: COMPARATOR
Intervention: Non-Ketogenic Diet (NKD)
Number of subjects: 21
Study 35751549 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry cupping therapy (DCT) for 8 minutes daily for 15 days (Group A)
Number of subjects: 45
Study 35751549 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry cupping therapy (DCT) for 10 minutes daily for 15 days (Group B)
Number of subjects: 45
Study 35751549 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry cupping therapy (DCT) for 12 minutes daily for 15 days (Group C)
Number of subjects: 45
Study 33445205 — intervention group
Group type: EXPERIMENTAL
Intervention: GPB 1% cream
Number of subjects: 171
Study 33445205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 32125555 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy supplemented with 750 mg of S. boulardii CNCM I-745 daily for 2 weeks
Number of subjects: 63
Study 32125555 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 63
Study 35948848 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised personal training (PT)
Number of subjects: 37
Study 35948848 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group-based (GROUP) program
Number of subjects: 37
Study 35948848 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based, smartphone-assisted exercise (HOME) intervention
Number of subjects: 37
Study 35948848 — intervention group
Group type: COMPARATOR
Intervention: Baseline predictors (Aesthetics domain of NEWS questionnaire)
Number of subjects: 37
Study 32967000 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic dose)
Number of subjects: 265
Study 32967000 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 265
Study 32967000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study 32807106 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible fibreoptic intubation
Number of subjects: 30
Study 32807106 — intervention group
Group type: COMPARATOR
Intervention: Conventional intubation
Number of subjects: 30
Study 35245668 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D echocardiography
Number of subjects: 748
Study 32867699 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-sodium phytate (99mTc-SP)
Number of subjects: 31
Study 32867699 — intervention group
Group type: COMPARATOR
Intervention: 99mTc-sulfur colloid (99mTc-SC)
Number of subjects: 31
Study 32867699 — intervention group
Group type: EXPERIMENTAL
Intervention: Both radiotracers
Number of subjects: 31
Study 35985959 — intervention group
Group type: EXPERIMENTAL
Intervention: CyBorD-DARA (Daratumumab with cyclophosphamide, bortezomib, and dexamethasone)
Number of subjects: 0
Study 35985959 — intervention group
Group type: EXPERIMENTAL
Intervention: CyBorD-DARA
Number of subjects: 0
Study 33082219 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop oxygen control
Number of subjects: 42
Study 33082219 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 42
Study 33082219 — intervention group
Group type: COMPARATOR
Intervention: Fixed concentration of 28% oxygen
Number of subjects: 42
Study 33082219 — intervention group
Group type: COMPARATOR
Intervention: 28% oxygen
Number of subjects: 42
Study 34740318 — intervention group
Group type: EXPERIMENTAL
Intervention: BPS + NFRT
Number of subjects: 114
Study 34740318 — intervention group
Group type: COMPARATOR
Intervention: BPS
Number of subjects: 114
Study 35397179 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional education module (Group I) using verbal explanation supported by photographs.
Number of subjects: 20
Study 35397179 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized VR based educational video (Group II).
Number of subjects: 20
Study 34390556 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weekly stress management sessions
Number of subjects: 144
Study 34390556 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 144
Study 33119680 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescribed medications during the previous year
Number of subjects: 326450
Study 33119680 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally acting antacids
Number of subjects: 326450
Study 33119680 — intervention group
Group type: EXPERIMENTAL
Intervention: Propulsives
Number of subjects: 326450
Study 33119680 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A and D
Number of subjects: 326450
Study 33119680 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop diuretics (e.g., furosemide)
Number of subjects: 326450
Study 33119680 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazide diuretics
Number of subjects: 326450
Study 33119680 — intervention group
Group type: EXPERIMENTAL
Intervention: Major cardiovascular drug classes
Number of subjects: 326450
Study 35254765 — intervention group
Group type: EXPERIMENTAL
Intervention: CAL/BDP PAD-cream
Number of subjects: 1271
Study 35254765 — intervention group
Group type: COMPARATOR
Intervention: CAL/BDP suspension/gel
Number of subjects: 1271
Study 33465838 — intervention group
Group type: COMPARATOR
Intervention: Partial range of motion (ROM) training (9º)
Number of subjects: 15
Study 33465838 — intervention group
Group type: COMPARATOR
Intervention: Full range of motion (ROM) training
Number of subjects: 15
Study 32639688 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster needling of scalp acupuncture on top of drug treatment
Number of subjects: 56
Study 32639688 — intervention group
Group type: COMPARATOR
Intervention: Drug treatment only
Number of subjects: 56
Study 35466438 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib suspension (Acala-NG) administered via NG tube
Number of subjects: 0
Study 35466438 — intervention group
Group type: EXPERIMENTAL
Intervention: Acalabrutinib suspension (Acala-NG) with PPI (rabeprazole)
Number of subjects: 0
Study 35466438 — intervention group
Group type: COMPARATOR
Intervention: Oral acalabrutinib capsule administered with water
Number of subjects: 0
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (25 mg)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (50 mg)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (100 mg)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (200 mg)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (400 mg)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (800 mg)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (100 mg, MAD)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (200 mg, MAD)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (400 mg, MAD)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (100 mg, steady state)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (200 mg, steady state)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (400 mg, steady state)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (SAD >100 mg)
Number of subjects: 100
Study 33653620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH3127 (MADs)
Number of subjects: 100
Study 33653620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32813290 — intervention group
Group type: EXPERIMENTAL
Intervention: adaptive dual n-back task
Number of subjects: 44
Study 32813290 — intervention group
Group type: COMPARATOR
Intervention: active control task
Number of subjects: 44
Study 33464969 — intervention group
Group type: EXPERIMENTAL
Intervention: Death narratives
Number of subjects: 1010
Study 33464969 — intervention group
Group type: EXPERIMENTAL
Intervention: Foreshadowed death narratives
Number of subjects: 1010
Study 33464969 — intervention group
Group type: COMPARATOR
Intervention: Survivor narratives
Number of subjects: 1010
Study 33689238 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal 25mcg misoprostol
Number of subjects: 90
Study 33689238 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal 4000mg evening primrose oil (EPO)
Number of subjects: 90
Study 33689238 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-balloon catheter
Number of subjects: 90
Study 35253453 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message intervention to improve sexual health outcomes
Number of subjects: 6250
Study 35253453 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment strategies aimed at engaging and motivating recruiting staff
Number of subjects: 6250
Study 32646041 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized neuromuscular electrical stimulation (NMES) with chewing exercises
Number of subjects: 40